Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $119.80 | $24.85 | 382.14% | 226.04x | 205.35x | 15.20x | 18.35x | 1.75x | $106.92M | 0.85% | $705.78M | 6.70 | $12.85B | 1,637.80 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $239.00 | $95.79 | 149.49% | 39.18x | 32.99x | 6.65x | 23.62x | 1.19x | $793.95M | 2.49% | $1.35B | 10.14 | $33.26B | 28.20 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $25.14 | $8.41 | 198.96% | 119.71x | 156.25x | 7.07x | 14.33x | 1.11x | $39.15M | 1.19% | $220.58M | 1.69 | $3.24B | 71.37 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $78.68 | $16.63 | 373.13% | 73.53x | 62.49x | 7.26x | 9.38x | 2.28x | $182.84M | 3.00% | $654.15M | 8.43 | $5.97B | 49.79 | ||
| KRYS | KRYSTAL BIOTECH INC | $359.76 | $87.44 | 311.43% | 43.50x | 47.17x | 24.12x | 7.83x | 2.56x | $257.78M | 2.43% | $1.36B | 46.03 | $10.23B | 43.85 | ||
| HALO | HALOZYME THERAPEUTICS INC | $107.06 | $71.77 | 49.18% | 30.07x | 12.90x | 7.55x | 84.65x | 0.65x | $806.22M | 6.42% | $143.54M | 1.22 | $14.13B | 19.67 | ||
| RPRX | ROYALTY PHARMA PLC | $61.80 | $38.99 | 58.48% | 32.87x | 11.52x | 10.85x | 3.63x | 0.68x | $2.92B | 10.63% | $9.79B | 21.99 | $43.68B | 37.14 | ||
| ADMA | ADMA BIOLOGICS INC | $9.63 | $8.84 | 8.88% | 13.38x | 11.48x | 4.29x | 5.28x | 0.60x | $116.47M | 5.30% | $408.21M | 1.79 | $2.22B | 9.52 | ||
| VCEL | VERICEL CORP | $42.44 | $9.00 | 371.49% | 88.42x | 88.03x | 7.08x | 5.87x | 2.09x | $61.66M | 2.84% | $370.04M | 7.25 | $2.14B | 48.59 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $65.61 | $21.50 | 205.16% | 172.66x | 17.66x | 3.73x | 2.01x | 1.09x | $738.18M | 5.82% | $6.32B | 32.68 | $16.01B | 41.52 | ||
| TGTX | TG THERAPEUTICS INC | $55.03 | $24.15 | 127.86% | 17.87x | 39.05x | 9.76x | 13.94x | 2.09x | $17.39M | 0.22% | $604.08M | 4.26 | $8.69B | 62.44 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.74 | $9.56 | 22.79% | 12.36x | 11.34x | 5.10x | 3.20x | 0.80x | $82.01M | 11.81% | $217.65M | 3.68 | $553.34M | 7.16 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.30 | $2.27 | 45.67% | 16.50x | 14.27x | 2.03x | 3.16x | 0.85x | $5.67M | 2.18% | $82.53M | 1.04 | $196.70M | 10.53 | ||
| TECH | BIO-TECHNE CORP | $72.38 | $17.62 | 310.85% | 61.86x | 34.69x | 9.29x | 5.38x | 2.01x | $263.22M | 2.33% | $2.11B | 13.52 | $11.37B | 32.72 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.22 | $6.52 | -81.29% | 8.71x | -4.12x | 1.50x | 1.61x | 0.07x | $19.58M | 27.70% | $44.20M | 0.76 | $22.32M | 2.92 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $249.29 | $197.24 | 26.39% | 16.34x | 9.66x | 3.42x | 3.37x | 0.67x | $1.62B | 10.28% | $4.80B | 75.98 | $18.96B | 11.73 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $287.85 | $94.56 | 204.41% | 28.58x | 31.15x | 19.88x | 5.93x | 2.15x | $130.62M | 2.26% | $967.52M | 48.22 | $5.86B | 21.02 | ||
| EXEL | EXELIXIS INC | $56.10 | $28.76 | 95.06% | 17.05x | 17.44x | 5.78x | 7.54x | 1.51x | $1.17B | 8.33% | $1.84B | 7.35 | $13.79B | 12.67 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $547.29 | $158.95 | 244.32% | 31.58x | 28.30x | 11.03x | 6.85x | 2.50x | $3.80B | 2.73% | $20.25B | 79.81 | $134.55B | 24.45 | ||
| MDXG | MIMEDX GROUP INC | $4.42 | $1.12 | 294.44% | 110.50x | -39.39x | 1.84x | 2.98x | 1.56x | $44.50M | 6.81% | $216.00M | 1.46 | $525.63M | 23.04 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $814.79 | $419.75 | 94.11% | 19.43x | 17.45x | 5.39x | 2.65x | 1.28x | $3.76B | 4.49% | $31.71B | 308.48 | $84.14B | 14.63 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.66 | $33.18 | 19.53% | 12.63x | 10.45x | 2.39x | 2.31x | 0.74x | $354.90M | 15.45% | $999.24M | 17.25 | $1.91B | 6.83 | ||
| UTHR | UNITED THERAPEUTICS CORP | $516.68 | $226.17 | 128.44% | 17.09x | 18.88x | 6.98x | 3.46x | 2.30x | $1.09B | 4.97% | $6.40B | 150.24 | $20.36B | 12.14 | ||
| INCY | INCYTE CORP | $128.12 | $60.88 | 110.45% | 15.78x | 16.86x | 4.41x | 4.09x | 2.11x | $1.92B | 7.48% | $6.34B | 31.66 | $22.02B | 10.65 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.